Anupam Rasayan India Ltd (BOM:543275)

Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	123,178	83,482	95,563	92,995	82,649	48,877
Market Cap Growth	-12.64%	-12.64%	2.76%	12.52%	69.09%	-
Enterprise Value	137,878	97,865	103,429	100,608	85,853	57,522
Last Close Price	1120.15	762.05	867.43	861.26	817.33	486.77
PE Ratio	131.95	89.43	74.31	51.42	54.31	69.53
PS Ratio	8.57	5.81	6.48	5.81	7.70	5.99
PB Ratio	4.00	2.71	3.26	3.71	4.79	3.11
P/TBV Ratio	4.56	3.09	3.65	4.16	4.82	3.13
P/FCF Ratio	-	-	-	130.42	-	-
P/OCF Ratio	-	-	161.88	31.84	-	3350.04
EV/Sales Ratio	9.60	6.81	7.01	6.28	8.00	7.05
EV/EBITDA Ratio	34.39	24.41	27.48	23.43	28.34	28.49
EV/EBIT Ratio	46.18	32.78	34.29	27.91	35.07	37.78
EV/FCF Ratio	-31.33	-	-	141.10	-	-
Debt / Equity Ratio	0.45	0.45	0.37	0.33	0.48	0.27
Debt / EBITDA Ratio	3.43	3.43	2.81	1.90	2.74	2.08
Debt / FCF Ratio	-	-	-	11.52	-	-
Asset Turnover	0.29	0.29	0.35	0.48	0.41	0.41
Inventory Turnover	0.48	0.48	0.63	0.80	0.55	0.86
Quick Ratio	0.48	0.48	0.72	1.32	0.60	1.16
Current Ratio	1.42	1.42	1.69	2.60	2.43	2.59
Return on Equity (ROE)	5.32%	5.32%	6.16%	10.24%	9.22%	6.49%
Return on Assets (ROA)	3.78%	3.78%	4.50%	6.76%	5.90%	4.80%
Return on Capital (ROIC)	4.41%	4.41%	5.14%	7.65%	6.71%	5.52%
Return on Capital Employed (ROCE)	8.60%	8.60%	9.20%	12.20%	10.70%	8.10%
Earnings Yield	0.76%	1.12%	1.35%	1.94%	1.84%	1.44%
FCF Yield	-3.57%	-5.27%	-6.88%	0.77%	-3.85%	-2.96%
Dividend Yield	0.07%	-	0.14%	0.29%	0.18%	0.10%
Payout Ratio	14.37%	14.37%	20.46%	13.58%	6.57%	-
Buyback Yield / Dilution	-1.40%	-1.40%	-4.18%	-3.69%	-22.04%	-7.62%
Total Shareholder Return	-1.34%	-1.40%	-4.03%	-3.40%	-21.85%	-7.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.